Identification and validation of cryptochrome inhibitors that modulate the molecular circadian clock.

Circadian rhythms, biological oscillations with a period of about 24 h, are maintained by a genetically determined innate time-keeping system called the molecular circadian clockwork. Despite the physiological and clinical importance of the circadian clock, the development of small molecule modulators that directly target the core clock machinery has only been recently initiated. In the present study, we aimed to identify novel small molecule modulators influencing the molecular feedback loop of the circadian clock by applying our two-step cell-based screening strategy based on E-box-mediated transcriptional activity to test more than 1000 drug-like compounds. A derivative of 2-ethoxypropanoic acid designated as compound 15 was selected as the most promising candidate in terms of both efficacy and potency. We then performed pull-down assays with the biotinylated compound and find out that both cryptochrome (CRY)1 and 2 (CRY1/2), key negative components of the mammalian circadian clock, as molecular targets of compound 15. In accordance with the binding property, compound 15 enhanced E-box-mediated transcription in a CRY1/2-dependent manner, and more importantly, it attenuated the circadian oscillation of Per2-Luc and Bmal1-dLuc activities in cultured fibroblasts, indicating that compound 15 can functionally inhibit the effects of CRY1/2 in the molecular circadian clockwork. In conclusion, the present study describes the first novel chemical inhibitor of CRY1/2 that inhibits the repressive function of CRY1/2, thereby activating CLOCK-BMAL1-evoked E-box-mediated transcription. Further optimizations and subsequent functional studies of this compound may lead to development of efficient therapeutic strategies for a variety of physiological and metabolic disorders with circadian natures.

[1]  M. Harrington,et al.  Circadian Clock Disruption , 2015 .

[2]  J. Lee,et al.  DNA damage-specific control of cell death by cryptochrome in p53-mutant ras-transformed cells. , 2013, Cancer research.

[3]  Ioana Visan,et al.  Circadian rhythms , 2012, Nature Immunology.

[4]  Peter C. St. John,et al.  Identification of Small Molecule Activators of Cryptochrome , 2012, Science.

[5]  Noheon Park,et al.  Chronic circadian disturbance by a shortened light-dark cycle increases mortality , 2012, Neurobiology of Aging.

[6]  Logan J Everett,et al.  Rev-erbα and Rev-erbβ coordinately protect the circadian clock and normal metabolic function. , 2012, Genes & development.

[7]  J. Takahashi,et al.  Regulation of Circadian Behavior and Metabolism by Synthetic REV-ERB Agonists , 2012, Nature.

[8]  Satchidananda Panda,et al.  Regulation of Circadian Behavior and Metabolism by Rev-erbα and Rev-erbβ , 2012, Nature.

[9]  R. Kondratov,et al.  The circadian clock and pathology of the ageing brain , 2012, Nature Reviews Neuroscience.

[10]  P. Schultz,et al.  A small molecule modulates circadian rhythms through phosphorylation of the period protein. , 2011, Angewandte Chemie.

[11]  J. Lee,et al.  Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis , 2011, Proceedings of the National Academy of Sciences.

[12]  Carsten C. Mahrenholz,et al.  Quantitative Analyses of Cryptochrome-mBMAL1 Interactions , 2011, The Journal of Biological Chemistry.

[13]  D. Kojetin,et al.  Identification of SR8278, a synthetic antagonist of the nuclear heme receptor REV-ERB. , 2011, ACS chemical biology.

[14]  Peter G. Schultz,et al.  High-Throughput Chemical Screen Identifies a Novel Potent Modulator of Cellular Circadian Rhythms and Reveals CKIα as a Clock Regulatory Kinase , 2010, PLoS biology.

[15]  Dmitri A. Nusinow,et al.  Cryptochrome Mediates Circadian Regulation of cAMP Signaling and Hepatic Gluconeogenesis , 2010, Nature Medicine.

[16]  T. Willson,et al.  GSK4112, a small molecule chemical probe for the cell biology of the nuclear heme receptor Rev-erbα. , 2010, ACS chemical biology.

[17]  Kathryn Moynihan Ramsey,et al.  Circadian Rhythms and Metabolic Syndrome: From Experimental Genetics to Human Disease , 2010, Circulation research.

[18]  Andrew I. Su,et al.  A Genome-wide RNAi Screen for Modifiers of the Circadian Clock in Human Cells , 2009, Cell.

[19]  J. Takahashi,et al.  Circadian Clock Feedback Cycle Through NAMPT-Mediated NAD+ Biosynthesis , 2009, Science.

[20]  P. Sassone-Corsi,et al.  Circadian Control of the NAD+ Salvage Pathway by CLOCK-SIRT1 , 2009, Science.

[21]  Satchidananda Panda,et al.  Network Features of the Mammalian Circadian Clock , 2009, PLoS biology.

[22]  Sooyoung Chung,et al.  Adrenal peripheral clock controls the autonomous circadian rhythm of glucocorticoid by causing rhythmic steroid production , 2008, Proceedings of the National Academy of Sciences.

[23]  Erin L. McDearmon,et al.  The genetics of mammalian circadian order and disorder: implications for physiology and disease , 2008, Nature Reviews Genetics.

[24]  Hyun-Jin Kang,et al.  Design, synthesis, and biological evaluation of novel constrained meta-substituted phenyl propanoic acids as peroxisome proliferator-activated receptor alpha and gamma dual agonists. , 2008, Journal of Medicinal Chemistry.

[25]  Kai-Florian Storch,et al.  Physiological significance of a peripheral tissue circadian clock , 2008, Proceedings of the National Academy of Sciences.

[26]  J. Takahashi,et al.  cAMP-Dependent Signaling as a Core Component of the Mammalian Circadian Pacemaker , 2008, Science.

[27]  S. Khorasanizadeh,et al.  Identification of heme as the ligand for the orphan nuclear receptors REV-ERBα and REV-ERBβ , 2007, Nature Structural &Molecular Biology.

[28]  C. Green,et al.  Structure/Function Analysis of Xenopus Cryptochromes 1 and 2 Reveals Differential Nuclear Localization Mechanisms and Functional Domains Important forInteraction with and Repression of CLOCK-BMAL1 , 2007, Molecular and Cellular Biology.

[29]  F. Tamanini,et al.  Functional Evolution of the Photolyase/Cryptochrome Protein Family: Importance of the C Terminus of Mammalian CRY1 for Circadian Core Oscillator Performance , 2006, Molecular and Cellular Biology.

[30]  T. Hirota,et al.  Ser-557-phosphorylated mCRY2 Is Degraded upon Synergistic Phosphorylation by Glycogen Synthase Kinase-3β* , 2005, Journal of Biological Chemistry.

[31]  T. Todo,et al.  The cryptochromes , 2005, Genome Biology.

[32]  Andrew L. Lee,et al.  Role of structural plasticity in signal transduction by the cryptochrome blue-light photoreceptor. , 2005, Biochemistry.

[33]  Y. Fukada,et al.  Serine phosphorylation of mCRY1 and mCRY2 by mitogen‐activated protein kinase , 2004, Genes to cells : devoted to molecular & cellular mechanisms.

[34]  Sumio Sugano,et al.  A transcription factor response element for gene expression during circadian night , 2002, Nature.

[35]  Ueli Schibler,et al.  The Orphan Nuclear Receptor REV-ERBα Controls Circadian Transcription within the Positive Limb of the Mammalian Circadian Oscillator , 2002, Cell.

[36]  R. Leak,et al.  Suprachiasmatic nucleus organization , 2002, Cell and Tissue Research.

[37]  R. Barstead,et al.  Genome-wide RNAi. , 2001, Current opinion in chemical biology.

[38]  John B. Hogenesch,et al.  Mop3 Is an Essential Component of the Master Circadian Pacemaker in Mammals , 2000, Cell.

[39]  Steven M Reppert,et al.  mCRY1 and mCRY2 Are Essential Components of the Negative Limb of the Circadian Clock Feedback Loop , 1999, Cell.

[40]  Mark J. Zylka,et al.  A Molecular Mechanism Regulating Rhythmic Output from the Suprachiasmatic Circadian Clock , 1999, Cell.

[41]  D. P. King,et al.  Mammalian Circadian Autoregulatory Loop A Timeless Ortholog and mPer1 Interact and Negatively Regulate CLOCK-BMAL1-Induced Transcription , 1998, Neuron.

[42]  Y. Fujii‐Kuriyama,et al.  Transcriptionally active heterodimer formation of an Arnt-like PAS protein, Arnt3, with HIF-1a, HLF, and clock. , 1998, Biochemical and biophysical research communications.

[43]  U. Schibler,et al.  A Serum Shock Induces Circadian Gene Expression in Mammalian Tissue Culture Cells , 1998, Cell.

[44]  D. P. King,et al.  Role of the CLOCK protein in the mammalian circadian mechanism. , 1998, Science.

[45]  J. Hogenesch,et al.  The basic-helix-loop-helix-PAS orphan MOP3 forms transcriptionally active complexes with circadian and hypoxia factors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[46]  P. Tresco,et al.  A diffusible coupling signal from the transplanted suprachiasmatic nucleus controlling circadian locomotor rhythms , 1996, Nature.

[47]  T. Todo,et al.  Similarity Among the Drosophila (6-4)Photolyase, a Human Photolyase Homolog, and the DNA Photolyase-Blue-Light Photoreceptor Family , 1996, Science.

[48]  S. Khorasanizadeh,et al.  Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbeta. , 2007, Nature structural & molecular biology.

[49]  A. Hall,et al.  of the circadian clock , 2007 .

[50]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.